
Lateral Capital

Biotechnology company that discovers, develops, manufactures and delivers medicines for serious diseases

Amgen is a biotechnology company. It researches, develops, manufactures and distributes medicines for serious illnesses, and describes its work as combining biology with technology.
Patients, doctors, researchers and investors. Its site also covers governance, ethics and compliance policies, and publishes financial results.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-06. Organic ranks only; sponsored placements are never ranks.
No questions yet. Be the first to ask about Amgen.
Similar listings buyers compare against this one.

Lateral Capital

Long-term Australian private investor buying and funding mid-sized businesses through partnership with managers

UK organisation running social technology award and challenge programmes that fund and mentor ventures

Venture firm investing in startups and teams in India and around the world

Nobska Ventures

Healthcare venture fund backed by Blue Cross Blue Shield plans, investing in emerging health companies
Everything here links back to the same verified catalogue. Pick your next stop.